Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katie Cherenzia"'
Autor:
Taneisha Wilson, Katie Cherenzia, John L. Reagan, Dana L. Guyer, Catherine Trimbur, Jessica Nagy, Jon Meideros, Andrew Buksar, Priscilla Eskridge, David Gardner, Ilse Jenouri, Patrick T. McGann
Publikováno v:
Blood. 140:5013-5014
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad522d4f1d7418a70db3ed0c9a1f0701
https://doi.org/10.1182/blood-2022-170951
https://doi.org/10.1182/blood-2022-170951
Publikováno v:
Journal of Pain and Symptom Management. 63:828
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cc4d28a8060a3108312bd9ddbc8dd3c
https://doi.org/10.1016/j.jpainsymman.2022.02.293
https://doi.org/10.1016/j.jpainsymman.2022.02.293
Publikováno v:
Blood. 138:2054-2054
Introduction: Hydroxyurea (HU) was the first FDA-approved therapy for sickle cell anemia (SCA) and remains the most well-established disease-modifying therapy, reducing painful crisis and improving morbidity and mortality. HU improves outcomes throug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97442ef2c5a526e10e3df7163e1d39e9
https://doi.org/10.1182/blood-2021-153890
https://doi.org/10.1182/blood-2021-153890
Autor:
Katie Cherenzia
With the evolution of cancer care and chemotherapy agents over the last 15 years there has been an evident shift in care from the inpatient to the ambulatory setting. There is a growing need for cancer care, particularly in the ambulatory (outpatient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28f1a1574c4f302106f6e9c25fd5825c
https://doi.org/10.28971/532017ck96
https://doi.org/10.28971/532017ck96
Publikováno v:
Journal of Clinical Oncology. 37:251-251
251 Background: Addressing the opioid epidemic can be challenging in a large academic cancer program and necessitates the need for a multidisciplinary approach for implementation of a successful program. The oncologist has a challenging role caring f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a271e5b90e6c751c51f2cde28249306f
https://doi.org/10.1200/jco.2019.37.27_suppl.251
https://doi.org/10.1200/jco.2019.37.27_suppl.251
Publikováno v:
Blood. 132:4931-4931
Sickle cell disease is a genetic blood disorder with significant morbidity and mortality. This disease is characterized by vaso-occlusive pain crisis and end-organ damage, ultimately contributing to poor quality of life and reduced life expectancy. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58f964b8708ad1ca1288a020c3f7eeff
https://doi.org/10.1182/blood-2018-99-120138
https://doi.org/10.1182/blood-2018-99-120138